Dr. Vish Subramaniam to Present Poster at AACR 2025

We are pleased to announce that Dr. Vish Subramaniam, EMBioSys Co-Founder and Chief Scientific Officer, will be presenting a poster at the American Association for Cancer Research (AACR) on April 28, 2025. 

Dr. Subramaniam’s poster will focus on practical methods for delivering iEF (induced electric field) therapy for treatment of solid cancers, starting with triple-negative breast cancer.

Backed by over a decade of pre-clinical research and publications, iEF Therapy has demonstrated in animal models the ability to inhibit pulmonary metastasis, reduce tumor growth, boost the natural anti-tumor immune response, and in vitro improved cytotoxic activity of standard of care chemotherapeutic agents, all while selectively targeting only cancer cells.

We look forward to sharing the details of our compelling technology with the cancer community at the AACR meeting.